KLF9 and glioblastoma: In glioblastoma-derived neurospheres enriched with cancer stem cells, KLF9 was found to induce cell differentiation, suppress neurosphere formation, and inhibit xenograft growth by binding to the Notch1 promoter to repress Notch1 expression and downstream signaling.